Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Alyatec provides clinical trial services and operates an advanced environmental exposure chamber to evaluate the efficacy and safety of therapies for allergic and respiratory diseases. The company has supported clinical studies for major pharma partners such as Regeneron and Laboratoires Théa in areas like asthma and allergic rhinitis. It offers high patient recruitment capabilities due to its large database of well-characterized allergy patients. Notably involved in validation studies for allergen challenge models. No proprietary therapeutic programs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Alyatec.